Bg pattern

NOVOEIGHT 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use NOVOEIGHT 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

NovoEight250UI powder and solvent for solution for injection

NovoEight500UI powder and solvent for solution for injection

NovoEight1000UI powder and solvent for solution for injection

NovoEight1500UI powder and solvent for solution for injection

NovoEight2000UI powder and solvent for solution for injection

NovoEight3000UI powder and solvent for solution for injection

turoctocog alfa (human coagulation factor VIII (rDNA))

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is NovoEight and what is it used for
  2. What you need to know before you use NovoEight
  3. How to use NovoEight
  4. Possible side effects
  5. Storage of NovoEight
  6. Contents of the pack and other information

1. What is NovoEight and what is it used for

NovoEight contains the active substance turoctocog alfa, human coagulation factor VIII. Factor VIII is a protein that is naturally found in the blood and helps it to clot.

NovoEight is used to treat and prevent bleeding episodes in patients with haemophilia A (congenital factor VIII deficiency) and can be used in all age groups.

In patients with haemophilia A, factor VIII is missing or does not work properly. NovoEight replaces the missing or non-functioning factor VIII and helps the blood to form clots at the site of bleeding.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use NovoEight

Do not use NovoEight:

  • if you are allergic to the active substance or any of the other ingredients of this medicine (listed in section 6)
  • if you are allergic to hamster proteins.

Do not use NovoEight in any of the above cases. If you are not sure, talk to your doctor before using this medicine.

Warnings and precautions

Talk to your doctor before using NovoEight.

There is a small chance that an anaphylactic reaction (a sudden and severe allergic reaction) to NovoEight may occur. The first signs of an allergic reaction are rash, hives, itching, swelling of the lips and tongue, difficulty breathing, wheezing, chest tightness, feeling unwell and dizziness.

If any of these symptoms occur, stop the injection immediately and contact your doctor.

Talk to your doctor if you think that bleeding is not being controlled with the dose you are given, as there may be different reasons for this. Some people using this medicine may develop antibodies against factor VIII (also known as factor VIII inhibitors). Factor VIII inhibitors reduce the effectiveness of NovoEight in preventing or controlling bleeding. If this happens, you may need a higher dose of NovoEight or another medicine to control bleeding. Do not increase the total dose of NovoEight to control bleeding without talking to your doctor. You should tell your doctor if you have been previously treated with factor VIII medicines, especially if you have developed inhibitors, as the risk of this happening again is higher.

The formation of inhibitors (antibodies) is a known complication that can occur during treatment with all factor VIII medicines. These inhibitors, especially in large quantities, prevent the treatment from working properly, so you and your child will be carefully monitored for the development of such inhibitors. If you or your child's bleeding is not being controlled with NovoEight, contact your doctor immediately.

Other medicines and NovoEight

Tell your doctor if you are using, have recently used or might use any other medicines.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.

Driving and using machines

NovoEight has no influence on the ability to drive and use machines.

NovoEight contains sodium

This medicine contains 30.5 mg of sodium (the main component of cooking/table salt) per reconstituted vial. This is equivalent to 1.5% of the maximum recommended daily intake of sodium for an adult.

If you are on a controlled sodium diet, talk to your doctor.

3. How to use NovoEight

Treatment with NovoEight should be started by a doctor who has experience in the treatment of patients with haemophilia A. Follow the instructions for administration of this medicine exactly as told by your doctor. If you are not sure, talk to your doctor again.

Your doctor will calculate the dose for you based on your weight and what the medicine is being used for.

Prevention of bleeding

The usual dose of NovoEight is 20 to 50 international units (IU) per kg body weight. The injection is given every 2 or 3 days. In some cases, especially in younger patients, more frequent injections or higher doses may be needed.

Treatment of bleeding

The dose of NovoEight is calculated based on body weight and the desired factor VIII levels. The desired level of factor VIII depends on the severity and location of the bleeding.

Use in children and adolescents

NovoEight can be used in children of all ages. In children (under 12 years) higher doses or more frequent injections may be needed. Adolescents (over 12 years) can use the same dose as adults.

How NovoEight is given

NovoEight must be injected into a vein. See “Instructions for use of NovoEight” for more information.

If you use more NovoEight than you should

If you use more NovoEight than you should, contact your doctor or go to a hospital immediately.

If you forget to use NovoEight

If you miss a dose and do not know how to make up for it, contact your doctor.

If you stop using NovoEight

If you stop using NovoEight, you will no longer be protected against bleeding or an existing bleed may not stop. Do not stop using NovoEight without talking to your doctor first.

If you have any other questions on the use of this medicine, ask your doctor.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects can occur with this medicine.

If (rarely) severe and sudden allergic reactions (anaphylactic reactions) occur, the injection must be stopped immediately. If you experience any of the following symptoms, contact your doctor immediately:

  • difficulty breathing, breathlessness or wheezing
  • chest tightness
  • swelling of the lips and tongue
  • rash, hives, itching or generalised itching
  • feeling of dizziness or loss of consciousness
  • low blood pressure (pale and cold skin, palpitations).

Severe symptoms, including difficulty swallowing or breathing and redness and swelling of the face or hands, require urgent treatment immediately.

If you experience a severe allergic reaction, your doctor may change your medicine.

In previously untreated children with factor VIII medicines, inhibitor antibodies (see section 2) may be formed very commonly (more than 1 in 10 patients); however, in patients who have received previous treatment with factor VIII (more than 150 days of treatment), the risk is uncommon (less than 1 in 100 patients). If this happens to you or your child, the treatment may stop working properly and you or your child may experience persistent bleeding. If this happens, contact your doctor immediately.

Common side effects (may affect up to 1 in 10 people)

  • blood tests showing changes in liver function
  • reactions (redness and itching) at the injection site.

Common side effects (may affect up to 1 in 10 people) in previously untreated patients with factor VIII medicines

  • redness of the skin
  • vein inflammation
  • bleeding into joints
  • bleeding into muscle tissue
  • cough
  • redness around the injection site
  • vomiting.

Uncommon side effects (may affect up to 1 in 100 people)

  • feeling tired
  • headache
  • feeling dizzy
  • difficulty sleeping (insomnia)
  • palpitations
  • high blood pressure
  • rash
  • fever
  • feeling hot
  • muscle stiffness
  • muscle pain
  • pain in arms and legs
  • swelling of arms and legs
  • joint disease
  • bruising
  • heart attack.

Side effects in children and adolescents

The side effects seen in children and adolescents are the same as those seen in adults.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Vigilance System for Human Use: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of NovoEight

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and on the labels of the vial and the pre-filled syringe after EXP. The expiry date is the last day of the month stated.

Store in a refrigerator (2°C to 8°C).

Do not freeze.

Keep the vial in the outer packaging to protect it from light.

Before reconstitution, the NovoEight powder can be stored for:

  • up to 9 months at room temperature (≤30°C)

or

  • up to 3 months above room temperature (30°C to 40°C).

Once the product is removed from the refrigerator, it must not be returned to the refrigerator.

Please note the start date and storage temperature on the product packaging.

Once reconstituted, NovoEight must be used immediately. If you cannot use the reconstituted NovoEight solution immediately, you must use it within:

  • 24 hours stored between 2°C and 8°C
  • 4 hours stored at ≤30°C, for the product that has been stored for a single period of up to 9 months at room temperature (≤30°C).
  • 4 hours stored up to 40°C, for the product that has been stored for a single period of up to 3 months above room temperature (30°C to 40°C).

If you are not going to use the reconstituted medicine immediately, store it in the vial. Otherwise, it will no longer be sterile and could cause an infection. Do not store the solution unless you follow the advice of your doctor.

The powder in the vial is a white or slightly yellow powder. If the colour of the powder has changed, do not use it.

The reconstituted solution will be clear to slightly opalescent. Do not use this medicine if you notice it is cloudy or contains visible particles.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. Container Contents and Additional Information

Composition of NovoEight

  • The active substance is turoctocog alfa (human coagulation factor VIII (rDNA)). Each vial of NovoEight contains 250, 500, 1000, 1500, 2000 or 3000 IU of turoctocog alfa.
  • The other components are L-histidine, sucrose, polysorbate 80, sodium chloride, L-methionine, calcium chloride dihydrate, sodium hydroxide, and hydrochloric acid.
  • The components of the solvent are sodium chloride and water for injections.

After reconstitution with the supplied solvent (sodium chloride 9 mg/ml (0.9%) solution for injection), the prepared injection solution contains 62.5, 125, 250, 375, 500 or 750 IU of turoctocog alfa per ml respectively (based on the turoctocog alfa concentration, i.e. 250, 500, 1000, 1500, 2000 or 3000 IU).

Appearance of the Product and Container Contents

NovoEight is a powder and solvent for solution for injection. Each NovoEight container contains a vial with white or slightly yellowish powder, a pre-filled syringe with 4 ml of a colorless and transparent solution, a plunger rod, and a vial adapter.

Marketing Authorisation Holder and Manufacturer

Novo Nordisk A/S

Novo Allé

DK-2880 Bagsværd, Denmark

Date of Last Revision of this Leaflet:

Other Sources of Information

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.

Instructions for Use of NovoEight

READ THESE INSTRUCTIONS CAREFULLY BEFORE USING NOVOEIGHT.

NovoEight is supplied as a powder. Before injection (administration), it must be reconstituted with the supplied solvent in the syringe. The solvent is a sodium chloride 9 mg/ml (0.9%) solution. Reconstituted NovoEight must be injected into a vein (intravenous injection). The components of this container are designed to reconstitute and inject NovoEight.

You will also need an infusion set (tubing and butterfly needle), sterile alcohol swabs, gauze, and bandages. These devices are not included in the NovoEight container.

Do not use the equipment without having received proper training from your doctor or nurse.

Always wash your hands and ensure the area around you is clean.

When preparing and injecting the medication directly into the veins, it is essential to use a clean and germ-free (aseptic) technique.Inadequate technique can introduce germs that can infect the blood.

Do not open the equipment until you are ready to use it.

Do not use the equipment if it has been dropped or damaged.Use a new container instead.

Do not use the equipment if it has expired.Use a new container instead. The expiration date is printed on the outer packaging, the vial, the vial adapter, and the pre-filled syringe after EXP.

Do not use the equipment if you suspect it is contaminated.Use a new container instead.

Do not discard any components until the reconstituted solution has been injected.

The equipment is for single use only.

Contents

The container contains:

  • 1 vial with NovoEight powder
  • 1 vial adapter
  • 1 pre-filled syringe with solvent
  • 1 plunger rod (located under the syringe)

Glass vial with white NovoEight powder, rubber stopper covered by a light blue plastic capVial adapter with transparent protective cover and visible spike under the protective paper

Transparent pre-filled syringe with liquid, showing the stopper, tip, scale, and plunger indicated with arrows and labelsLong rod with thread at one end and wide end at the other, labeled with arrows and explanatory text

  1. Prepare the vial and syringe
  • Prepare the required number of NovoEight containers.
  • Check the expiration date.
  • Check the name, concentration, and color of the container to ensure it contains the correct product.
  • Wash your hands and dry them properly with a clean towel or air.
  • Remove the vial, vial adapter, and pre-filled syringe from the container. Leave the plunger rod untouched in the container.
  • Bring the vial and pre-filled syringe to room temperature. You can do this by holding both in your hands until you feel they are at the same temperature as your hands.
  • Do not use any other system to heat the vial and pre-filled syringe.

Two hands holding a device with a white cylinder and a blue cap preparing for use

  • Remove the plastic cap from the vial. If the plastic cap is loose or missing, do not use the vial.
  • Clean the rubber stopper with a sterile alcohol swab and let it air dry for a few seconds before using it to ensure it is as germ-free as possible.
  • Do not touch the rubber stopper with your fingers, as this can transfer germs.

Hand holding a medication vial with a needle inserted into the top stopper and an arrow indicating withdrawal

  1. Attach the vial adapter
  • Remove the protective paper from the vial adapter.

If the protective paperis not fully sealed or is broken, do not use the vial adapter.

Do not remove the vial adapter from the protective cover with your fingers.If you touch the spike of the vial adapter, you can transfer germs from your fingers.

Hands holding a transparent vial with liquid and a connected needle, arrow indicating direction of withdrawal

  • Place the vial on a flat, hard surface.
  • Place the protective cover of the vial adapter upside down and attach the vial adapter to the vial by pressing down.

Once attached, do not remove the vial adapter from the vial.

Hand holding a pre-filled injection device with an arrow pointing down and a vial below

  • Slightly compress the protective cover between your thumb and index finger as shown.

Remove the protective coverfrom the vial adapter.

Do not remove the vial adapterwhen removing the protective cover.

Hand holding an applicator with a needle over a medication vial and an arrow indicating direction upwards

  1. Attach the plunger rod and syringe
  • Hold the plunger rod by the wide end and remove it from the container. Do not touch the sides or thread of the plunger rod. If you touch the sides or thread, you can transfer germs from your fingers.
  • Immediately attach the plunger rod to the syringe by turning it to the right inside the plunger in the pre-filled syringe until you feel resistance.

Hands holding an auto-injector with a blue curved arrow indicating the direction of rotation to activate the device

  • Remove the cap from the pre-filled syringe by folding it downwards until the perforation breaks.
  • Do not touch the tip of the pre-filled syringe under the cap. If you touch the tip of the pre-filled syringe, you can transfer germs from your fingers.

If the cap of the pre-filled syringe is loose or missing, do not use the pre-filled syringe.

Hands holding a pre-filled injection device and a needle, showing the connection of the needle to the device with an arrow indicating direction

  • Tightly screw the pre-filled syringe onto the vial adapter until you feel resistance.

Hands holding two medication cartridges connected with an arrow indicating rotation to connect

  1. Reconstitute the powder with the solvent
  • Hold the pre-filled syringe slightly inclined with the vial pointing downwards.
  • Press the plunger rod to inject all the solvent into the vial.

Hand holding a pre-filled syringe with a blue arrow indicating the direction of needle insertion

  • Keep the plunger rod pressed and gently remove the vial until the powder is dissolved.

Do not shake the vial, as this would produce foam.

  • Check the reconstituted solution. It should be transparent or slightly opalescent (slightly less transparent). If it appears cloudy or contains visible particles, do not use it. Use a new container instead.

Hand holding an auto-injector with a visible needle and a connected vial rotating clockwise

It is recommended to use NovoEight immediately after reconstitution,as, if left, the medication may become non-sterile and could cause infections.

If you cannot use the reconstituted NovoEight solution immediately,you must use it within 4 hours if stored at room temperature or up to 40°C and within 24 hours if stored between 2°C and 8°C. Store the reconstituted product in the vial.

Do not freeze the reconstituted NovoEight solution or store it in syringes.

Do not store the solution without the advice of your doctor.

Store the reconstituted NovoEight solution away from direct light.

If your dose requires more than one vial, repeat steps Ato Jwith additional vials, vial adapters, and pre-filled syringes until the required dose is reached.

  • Keep the plunger rod fully pushed in.
  • Place the syringe with the vial upside down.
  • Stop pushing the plunger rod and let it retract by itself while the reconstituted solution fills the syringe.
  • Pull the plunger rod slightly downwards to pass the reconstituted solution into the syringe.
  • If you only need part of the vial, use the syringe scale to see the amount of reconstituted solution you have withdrawn, as instructed by your doctor or nurse.

If there is too much air in the syringe at any time, inject the air back into the vial.

  • While holding the vial upside down, gently tap the syringe to allow any bubbles to rise to the top.
  • Slowly push the plunger rod until all bubbles have been eliminated.

Hand holding a pre-filled syringe with transparent medication and a descending plunger indicated by a blue arrow

  • Unscrew the adapter with the vial.
  • Do not touch the tip of the syringe. If you touch the tip of the syringe, you can transfer germs from your fingers.

Connection of a pre-filled syringe to a needle with blue arrows indicating the rotational movement of connection

  1. Inject the reconstituted solution

NovoEight is now ready to be injected into a vein.

  • Inject the reconstituted solution following the instructions of your doctor or nurse.
  • Inject slowly over 2 to 5 minutes.
  • Do not mix NovoEight with any other infusion or intravenous medication.

Injection of NovoEight through needleless connectors for intravenous (IV) catheters

Precaution:the pre-filled syringe is made of glass and is designed to be compatible with standard luer-lock connections. Some needleless connectors with an internal spike are incompatible with the pre-filled syringe. This incompatibility can prevent administration of the medication and/or damage the needleless connector.

Injection of the solution through a central venous access device (CVAD) such as a central venous catheter or a subcutaneous port:

  • Use a clean and germ-free (aseptic) technique. Follow the instructions for the proper use of your connector and CVAD with the advice of your doctor or nurse.
  • Injection into a CVAD may require using a sterile 10 ml plastic syringe to withdraw the reconstituted solution. This should be done immediately after step J.
  • If it is necessary to flush the CVAD line before or after the injection of NovoEight, use a sodium chloride 9 mg/ml solution for injection.

Disposal

  • After injection, safely discard any unused NovoEight solution, the syringe with the infusion set, the vial with the vial adapter, and other waste following the instructions of your pharmacist.

Do not dispose of them as ordinary household waste.

Blue vial with cap, connected needle, and small vial with transparent liquid, arrow indicating direction

Do not disassemble the equipment before disposing of it.

Do not reuse the equipment.

Online doctors for NOVOEIGHT 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Discuss questions about NOVOEIGHT 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (140)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (29)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for NOVOEIGHT 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION?
NOVOEIGHT 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in NOVOEIGHT 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION?
The active ingredient in NOVOEIGHT 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION is coagulation factor VIII. This information helps identify medicines with the same composition but different brand names.
Who manufactures NOVOEIGHT 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION?
NOVOEIGHT 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION is manufactured by Novo Nordisk A/S. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of NOVOEIGHT 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether NOVOEIGHT 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to NOVOEIGHT 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION?
Other medicines with the same active substance (coagulation factor VIII) include ADVATE 1,000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION, ADVATE 1500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION, ADVATE 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media